BioSpace News Archive

Business

Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology

Bayer and Cedilla Therapeutics today announced an exclusive license agreement to develop and commercialize Cedilla Therapeutics’ CyclinE1/CDK2 complex inhibitors which selectively address oncogenic drivers.

June 1, 2023
·
3 min read
Human Liver Models Market Size ($508.26Mn by 2028) Lead by Liver-on-a-Chip Type (11.7% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com

The new research study on the Human Liver Models Market Size and Forecast to 2028 by Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others)

June 1, 2023
·
5 min read
Point-of-Care Molecular Diagnostics Market Size ($5,381.18Mn by 2028) Lead by Assays and Kits (13.4% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com

According to our new research study on Point-of-Care Molecular Diagnostics Market Size and Forecast to 2028 - COVID-19 Impact and Global Analysis By Product & Services (Assays and Kits, Instruments, and Services and Software)

June 1, 2023
·
6 min read
Blood Brain Barrier Technologies Market (Technology, Application) Size ($5,101.94Mn by 2028) Lead by Neurological Disorders (25.5% CAGR) During 2021-2028 | The Insight Partners

The new research study on the Blood Brain Barrier Technologies Market Size and Forecast to 2028 By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, and Other Non-Invasive BBB Technologies)

June 1, 2023
·
6 min read
Extracellular Matrix Market (Raw Material, Application) Size Worth $52.72Mn, Globally, by 2028 at 7.6% CAGR - Exclusive Report by The Insight Partners

The latest research study on “Extracellular Matrix Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Raw Material (Bovine, Porcine, and Other Raw Material) and Application (Soft Tissue Repair, Dural Repair, Wound Healing

June 1, 2023
·
7 min read
3D Printing Medical Devices Market (Component, Technology) Size, $6,583.50 Million by 2028 Lead by Software and Services, 17.5% CAGR - Exclusive Research Report by The Insight Partners

According to our new research study on “3D Printing Medical Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Component [Software and Services

June 1, 2023
·
6 min read
Biotech Beach

Navigate BioPharma Services, Inc. launches new multiplex digital PCR assay for comprehensive quantification of up to 5 different CAR-T transgenes

During this year’s AAPS National biotechnology conference, Navigate BioPharma Services, Inc. announced the launch of its new multiplex digital PCR assays for comprehensive quantification of multiple chimeric antigen receptor (CAR) T cells, a type of cancer immunotherapy that involves genetically modifying T cells to recognize and destroy certain cancers.

June 1, 2023
·
2 min read
Biotech Beach

CureScience™ Institute Publishes A Review Article on Neoantigens

CureScience™ Institute is pleased to announce the publication of “Designing neoantigen cancer vaccines, trials, and outcomes” by Biswas, N., Chakrabarti, S., Padul, V., Jones, L. D., & Ashili, S.

June 1, 2023
·
2 min read
Biotech Beach

TORL BioTherapeutics Announces Initial Results of Novel Claudin 6 (CLDN6) Targeted Antibody Drug Conjugate (ADC) TORL-1-23 Selected for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

TORL BioTherapeutics LLC announces the initial results from an ongoing phase I study of their claudin 6 targeted antibody drug conjugate, TORL-1-23, in patients with advanced cancer on the American Society of Oncology website.

June 1, 2023
·
4 min read
Business

Levolta Pharmaceuticals Partners with Tabuk Pharmaceuticals for Commercialization of Investigational Osteoarthritis Therapy in Middle East and Africa

Levolta Pharmaceuticals, Inc. has entered into an exclusive licensing and distribution agreement for VOLT01 with Tabuk Pharmaceutical Manufacturing Company of Riyadh, Saudi Arabia, for the commercialization of an investigational osteoarthritis (OA) therapy in the Middle East and Africa (MEA) region, excluding South Africa.

June 1, 2023
·
4 min read